Home > Aerospace and Defence > Global Nanoparticles Market in Biotechnology and Pharmaceutical Sectors 2017-2021...

Global Nanoparticles Market in Biotechnology and Pharmaceutical Sectors 2017-2021

No. of Pages: 88Published : 20 Nov 2017

Request Sample
 

About Nanoparticles Nanoparticles are sub-nanosized colloidal structures composed of synthetic or semi-synthetic polymers. These are used in biotechnology and pharmaceutical sectors for studying biological systems for diagnosing diseases and focusing on treatment at the molecular level. The properties of many conventional materials alter when formed from nanoparticles, the reason being nanoparticles have a greater surface area per weight than larger particles, making them more reactive to other molecules Technavio?s analysts forecast the global nanoparticles market in biotechnology and pharmaceutical sectors to grow at a CAGR of 21.72% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global nanoparticles market in biotechnology and pharmaceutical sectors for 2017-2021. To calculate the market size, the report considers the revenue generated from the retail sales of nanoparticles in the aforesaid sectors. The market is divided into the following segments based on geography: ? Americas ? APAC ? EMEA Technavio's report, Global Nanoparticles Market in Biotechnology and Pharmaceutical Sectors 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors ? F. Hoffmann-La Roche ? GE Healthcare ? Merck ? Novartis Other prominent vendors ? AMAG Pharmaceuticals ? Amgen ? Bausch & Lomb ? Biogen ? Celgene ? Gilead ? Ipsen ? Leadiant Biosciences ? nanoComposix ? Pacira Pharmaceuticals ? Pfizer ? Shire ? UCB Market driver ? Rising R&D expenditure in pharmaceutical and biotechnology sectors ? For a full, detailed list, view our report Market challenge ? Challenges in development of nanoparticles for therapeutics ? For a full, detailed list, view our report Market trend ? Increasing demand for nanoparticles in stem cell therapy ? For a full, detailed list, view our report Key questions answered in this report ? What will the market size be in 2021 and what will the growth rate be? ? What are the key market trends? ? What is driving this market? ? What are the challenges to market growth? ? Who are the key vendors in this market space? You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.

 

Table of Contents PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: INTRODUCTION ? Market outline PART 05: MARKET LANDSCAPE ? Market size and forecast ? Five forces analysis PART 06: MARKET SEGMENTATION BY END-USER ? Comparison by end-user ? Biotechnology ? Pharmaceutical ? Market opportunity by end-user PART 07: REGIONAL LANDSCAPE ? Regional comparison ? Nanoparticles market in biotechnology and pharmaceutical sectors in Americas ? Nanoparticles market in biotechnology and pharmaceutical sectors in EMEA ? Nanoparticles market in biotechnology and pharmaceutical sectors in APAC ? Market opportunity PART 08: DECISION FRAMEWORK PART 09: DRIVERS AND CHALLENGES ? Market drivers ? Market challenges PART 10: MARKET TRENDS ? Increasing demand for nanoparticles in stem cell therapy ? Increasing prevalence of chronic diseases ? Increasing use of gold nanoparticles PART 11: VENDOR LANDSCAPE ? Competitive scenario ? Investment opportunity PART 12: VENDOR ANALYSIS ? Vendor overview ? Merck ? F. Hoffmann-La Roche ? GE Healthcare ? Novartis ? Other prominent vendors PART 13: APPENDIX ? List of abbreviations List of Exhibits Exhibit 01: Applications of nanoparticles in biotechnology and pharmaceutical sectors Exhibit 02: Detection of cancer cells in bloodstream through use of nanoparticles Exhibit 03: Global nanoparticles market in biotechnology and pharmaceutical sectors: Market overview Exhibit 04: Global nanoparticles market in biotechnology and pharmaceutical sectors 2016-2021 ($ billions) Exhibit 05: Five forces analysis Exhibit 06: Global nanoparticles market in biotechnology and pharmaceutical sectors by end-user 2016-2021 (% share) Exhibit 07: Comparison by end-user Exhibit 08: Global nanoparticles market by biotechnology 2016-2021 ($ billions) Exhibit 09: Global nanoparticles market by biotechnology ? Year over year growth Exhibit 10: Global nanoparticles market by pharmaceutical 2016-2021 ($ billions) Exhibit 11: Nanoparticles in pharmaceuticals Exhibit 12: Global nanoparticles market by pharmaceutical ? Year over year growth Exhibit 13: Global nanoparticles market in biotechnology and pharmaceutical sectors by region 2016-2021 (% share) Exhibit 14: Regional comparison Exhibit 15: Nanoparticles market in biotechnology and pharmaceutical sectors in Americas 2016-2021 ($ billions) Exhibit 16: Nanoparticles market in biotechnology and pharmaceutical sectors in Americas ? Year over year growth Exhibit 17: Top 3 countries in Americas Exhibit 18: Nanoparticles market in biotechnology and pharmaceutical sectors in EMEA 2016-2021 ($ billions) Exhibit 19: Nanoparticles market in biotechnology and pharmaceutical sectors in EMEA ? Year over year growth Exhibit 20: Top 3 countries in EMEA Exhibit 21: Nanoparticles market in biotechnology and pharmaceutical sectors in APAC 2016-2021 ($ billions) Exhibit 22: Nanoparticles market in biotechnology and pharmaceutical sectors in APAC ? Year over year growth Exhibit 23: Top 3 countries in APAC Exhibit 24: Nanoparticle-based products under clinical trials Exhibit 25: Major chronic disease-related deaths 2012 (in thousands) Exhibit 26: Strategic success factors for vendors to consider Exhibit 27: Investment opportunity mapping Exhibit 28: Merck: Profile Exhibit 29: Merck: Strength analysis Exhibit 30: Merck: Strategy assessment Exhibit 31: Merck: Opportunity assessment Exhibit 32: F. Hoffmann-La Roche: Profile Exhibit 33: F. Hoffmann-La Roche: Strength analysis Exhibit 34: F. Hoffmann-La Roche: Strategy assessment Exhibit 35: F. Hoffmann-La Roche: Opportunity assessment Exhibit 36: GE Healthcare: Profile Exhibit 37: GE Healthcare: Strength analysis Exhibit 38: GE Healthcare: Strategy assessment Exhibit 39: GE Healthcare: Opportunity assessment Exhibit 40: Novartis: Profile Exhibit 41: Novartis: Strength analysis Exhibit 42: Novartis: Strategy assessment Exhibit 43: Novartis: Opportunity assessment

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
 

 INFORMATION SOURCES:

Primary research - Manufacturers/Suppliers, Channel partners, Industry experts, Strategic decision makers
 

Secondary research - Technavio internal repository, Industry journals and periodicals, Government bodies, Annual reports of key stakeholders
 

DATA ANALYSIS:

Data synthesis - Collation of data, Estimation of key figure, Analysis of derived insights
 

Data validation - Triangulation with data models, Reference against proprietary databases, Corroboration with industry experts
 

REPORT WRITING

Qualitative analysis - Market drivers, Market challenges, Market trends, Five forces analysis
 

Quantitative analysis- Market size and forecast, Market segmentation, Geographical insights, Competitive landscape
 

Technavio’s database and industry-specific repositories are used for defining the hypothesis for the study, which is further fine-tuned through primary research involving industry experts. The success of our approach lies in the fact that we take the viewpoint of all stakeholders into consideration while analyzing an industry, and objectively assess each outlook. 
 

Report ID : MSF428864

Publisher Name : Technavio

Why Market Size Forecasters?

  • Reports at Lowest Prices - Guaranteed
  • Fastest Growing Research Reports’ Database
  • Easy Customization Options
  • 24 X 7 Support Commitment
  • Certified, Safe & Secured Payments

Have A Question?

Ask UsView FAQ's